carbon monoxide has been researched along with Stroke in 27 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Exhaled carbon monoxide (CO) is associated with cardiometabolic traits, subclinical atherosclerosis, and cardiovascular disease, but its specific relations with stroke are unexplored." | 7.83 | Association of Exhaled Carbon Monoxide With Stroke Incidence and Subclinical Vascular Brain Injury: Framingham Heart Study. ( Beiser, AS; Cheng, S; DeCarli, C; Enserro, DM; Nayor, M; Seshadri, S; Vasan, RS, 2016) |
| "Carbon monoxide (CO) is a gaseous second messenger produced when heme oxygenase enzymes catabolize heme." | 5.37 | Carbon monoxide-activated Nrf2 pathway leads to protection against permanent focal cerebral ischemia. ( Biswal, S; Cao, W; Doré, S; Wang, B, 2011) |
| "Exhaled carbon monoxide (CO) is associated with cardiometabolic traits, subclinical atherosclerosis, and cardiovascular disease, but its specific relations with stroke are unexplored." | 3.83 | Association of Exhaled Carbon Monoxide With Stroke Incidence and Subclinical Vascular Brain Injury: Framingham Heart Study. ( Beiser, AS; Cheng, S; DeCarli, C; Enserro, DM; Nayor, M; Seshadri, S; Vasan, RS, 2016) |
| "Carbon monoxide intoxication is the most prevalent cause of death from carbon monoxide poisoning." | 3.81 | Cerebrovascular ischaemia after carbon monoxide intoxication. ( Ak, A; Bayir, A; Degirmenci, S; Kara, H, 2015) |
| "We used a time-stratified case-crossover design to study the association between short-term exposure to UFPs, particulate matter <10 microm in diameter (PM(10)), nitrogen oxides (NO(x)) and carbon monoxide (CO) (measured at single background station) and hospital admissions for stroke in Copenhagen (2003-2006)." | 3.76 | Association between short-term exposure to ultrafine particles and hospital admissions for stroke in Copenhagen, Denmark. ( Andersen, KK; Andersen, ZJ; Ketzel, M; Loft, S; Olsen, TS; Raaschou-Nielsen, O, 2010) |
| "No treatment-emergent serious adverse events were reported." | 2.84 | Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): A Phase I Safety Clinical Trial. ( DiFede, D; Fishman, J; Glassberg, MK; Hare, JM; Khan, A; Lancaster, LH; LaRussa, VF; Mageto, YN; Mendizabal, A; Minkiewicz, J; Pujol, MV; Rosen, GD; Rubio, GA; Shafazand, S; Simonet, ES; Toonkel, RL, 2017) |
| "Smoking cessation is widely recommended for secondary stroke prevention." | 2.77 | Smoking cessation intervention after ischemic stroke or transient ischemic attack. A randomized controlled pilot trial. ( Bak, S; Brunner Frandsen, N; Henriksen, RM; Hyldahl, TK; Sørensen, M, 2012) |
| "Patent foramen ovale is seen in a quarter of patients with idiopathic pulmonary arterial hypertension and associated with increased prevalence of severe hypoxemia but had no effect on long term survival." | 1.43 | Patent foramen ovale in idiopathic pulmonary arterial hypertension: Long-term risk and morbidity. ( Gallo de Moraes, A; Moua, T; Vakil, A, 2016) |
| "Carbon monoxide (CO) is a gaseous second messenger produced when heme oxygenase enzymes catabolize heme." | 1.37 | Carbon monoxide-activated Nrf2 pathway leads to protection against permanent focal cerebral ischemia. ( Biswal, S; Cao, W; Doré, S; Wang, B, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (25.93) | 29.6817 |
| 2010's | 16 (59.26) | 24.3611 |
| 2020's | 4 (14.81) | 2.80 |
| Authors | Studies |
|---|---|
| Priyadharsini, P | 1 |
| Dawn, SS | 1 |
| Arun, J | 1 |
| Sathish, T | 1 |
| Teo, KK | 1 |
| Britz-McKibbin, P | 1 |
| Gill, B | 1 |
| Islam, S | 1 |
| Paré, G | 1 |
| Rangarajan, S | 1 |
| Duong, M | 1 |
| Lanas, F | 1 |
| Lopez-Jaramillo, P | 1 |
| Mony, PK | 1 |
| Pinnaka, L | 1 |
| Kutty, VR | 1 |
| Orlandini, A | 1 |
| Avezum, A | 1 |
| Wielgosz, A | 1 |
| Poirier, P | 1 |
| Alhabib, KF | 1 |
| Temizhan, A | 1 |
| Chifamba, J | 1 |
| Yeates, K | 1 |
| Kruger, IM | 1 |
| Khatib, R | 1 |
| Yusuf, R | 1 |
| Rosengren, A | 1 |
| Zatonska, K | 1 |
| Iqbal, R | 1 |
| Lui, W | 1 |
| Lang, X | 1 |
| Li, S | 1 |
| Hu, B | 1 |
| Dans, AL | 1 |
| Yusufali, AH | 1 |
| Bahonar, A | 1 |
| O'Donnell, MJ | 1 |
| McKee, M | 1 |
| Yusuf, S | 1 |
| Hu, W | 1 |
| Chen, Y | 1 |
| Chen, J | 1 |
| Abuchowski, A | 1 |
| Ha, S | 1 |
| Männistö, T | 1 |
| Liu, D | 1 |
| Sherman, S | 1 |
| Ying, Q | 1 |
| Mendola, P | 1 |
| Liu, H | 2 |
| Tian, Y | 2 |
| Xu, Y | 1 |
| Huang, Z | 1 |
| Huang, C | 1 |
| Hu, Y | 2 |
| Zhang, J | 1 |
| Nie, D | 1 |
| Chen, M | 2 |
| Wu, Y | 1 |
| Ge, X | 1 |
| Hu, J | 1 |
| Zhang, K | 1 |
| Ge, P | 1 |
| Dong, H | 1 |
| Yu, Y | 1 |
| Yao, S | 1 |
| Lu, Y | 1 |
| Chen, Z | 1 |
| Li, G | 1 |
| Yao, Y | 1 |
| Yao, X | 1 |
| Wang, SL | 1 |
| Zhang, Z | 1 |
| Zhao, Z | 1 |
| Xiang, X | 1 |
| Li, M | 1 |
| Juan, J | 1 |
| Song, J | 1 |
| Cao, Y | 1 |
| Wang, X | 1 |
| Chen, L | 2 |
| Wei, C | 1 |
| Gao, P | 1 |
| Luo, L | 1 |
| Dai, Y | 1 |
| Zhang, F | 1 |
| Chen, F | 1 |
| Qing, F | 1 |
| Kara, H | 1 |
| Bayir, A | 1 |
| Ak, A | 1 |
| Degirmenci, S | 1 |
| Tian, L | 1 |
| Qiu, H | 1 |
| Pun, VC | 1 |
| Ho, KF | 1 |
| Chan, CS | 1 |
| Yu, IT | 1 |
| Nayor, M | 1 |
| Enserro, DM | 1 |
| Beiser, AS | 1 |
| Cheng, S | 1 |
| DeCarli, C | 1 |
| Vasan, RS | 1 |
| Seshadri, S | 1 |
| Hampson, NB | 1 |
| Weaver, LK | 1 |
| Gallo de Moraes, A | 1 |
| Vakil, A | 1 |
| Moua, T | 1 |
| Glassberg, MK | 1 |
| Minkiewicz, J | 1 |
| Toonkel, RL | 1 |
| Simonet, ES | 1 |
| Rubio, GA | 1 |
| DiFede, D | 1 |
| Shafazand, S | 1 |
| Khan, A | 1 |
| Pujol, MV | 1 |
| LaRussa, VF | 1 |
| Lancaster, LH | 1 |
| Rosen, GD | 1 |
| Fishman, J | 1 |
| Mageto, YN | 1 |
| Mendizabal, A | 1 |
| Hare, JM | 1 |
| Andersen, ZJ | 1 |
| Olsen, TS | 1 |
| Andersen, KK | 1 |
| Loft, S | 1 |
| Ketzel, M | 1 |
| Raaschou-Nielsen, O | 1 |
| Wang, B | 1 |
| Cao, W | 1 |
| Biswal, S | 1 |
| Doré, S | 1 |
| Brunner Frandsen, N | 1 |
| Sørensen, M | 1 |
| Hyldahl, TK | 1 |
| Henriksen, RM | 1 |
| Bak, S | 1 |
| Bedada, GB | 1 |
| Smith, CJ | 1 |
| Tyrrell, PJ | 1 |
| Hirst, AA | 1 |
| Agius, R | 1 |
| Hong, YC | 1 |
| Lee, JT | 1 |
| Kim, H | 1 |
| Kwon, HJ | 1 |
| Yang, CY | 1 |
| Chen, YS | 1 |
| Yang, CH | 1 |
| Ho, SC | 1 |
| Maheswaran, R | 1 |
| Haining, RP | 1 |
| Brindley, P | 1 |
| Law, J | 1 |
| Pearson, T | 1 |
| Fryers, PR | 1 |
| Wise, S | 1 |
| Campbell, MJ | 1 |
| Hedblad, B | 1 |
| Ogren, M | 1 |
| Engström, G | 1 |
| Wollmer, P | 1 |
| Janzon, L | 1 |
| Bani-Hani, MG | 1 |
| Greenstein, D | 1 |
| Mann, BE | 1 |
| Green, CJ | 1 |
| Motterlini, R | 1 |
| Villeneuve, PJ | 1 |
| Stieb, D | 1 |
| Rowe, BH | 1 |
| Henrotin, JB | 1 |
| Besancenot, JP | 1 |
| Bejot, Y | 1 |
| Giroud, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase I, Randomized, Blinded and Placebo-controlled Trial to Evaluate the Safety, Tolerability, and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Infusion in Patients With Idiopathic Pulmonary Fibrosis[NCT02013700] | Phase 1 | 9 participants (Actual) | Interventional | 2013-11-13 | Terminated (stopped due to Study completed) | ||
| An Open Clinical Study to Explore the Safety, Tolerance and Preliminary Efficacy of Human Umbilical Cord Mesenchymal Stem Cell Injection in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)[NCT05468502] | Phase 1 | 18 participants (Anticipated) | Interventional | 2022-10-10 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for carbon monoxide and Stroke
| Article | Year |
|---|---|
Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): A Phase I Safety Clinical Trial.
Topics: Administration, Intravenous; Aged; Carbon Monoxide; Disease Progression; Dyspnea; Female; Hospitaliz | 2017 |
Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): A Phase I Safety Clinical Trial.
Topics: Administration, Intravenous; Aged; Carbon Monoxide; Disease Progression; Dyspnea; Female; Hospitaliz | 2017 |
Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): A Phase I Safety Clinical Trial.
Topics: Administration, Intravenous; Aged; Carbon Monoxide; Disease Progression; Dyspnea; Female; Hospitaliz | 2017 |
Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): A Phase I Safety Clinical Trial.
Topics: Administration, Intravenous; Aged; Carbon Monoxide; Disease Progression; Dyspnea; Female; Hospitaliz | 2017 |
Smoking cessation intervention after ischemic stroke or transient ischemic attack. A randomized controlled pilot trial.
Topics: Adult; Aged; Carbon Monoxide; Counseling; Female; Follow-Up Studies; Humans; Ischemic Attack, Transi | 2012 |
25 other studies available for carbon monoxide and Stroke
| Article | Year |
|---|---|
Four stroke diesel engine performance and emission studies of ethanol recovered from Kappaphycus alvarezii reject -solid food waste mixed substrates and its blends.
Topics: Biofuels; Carbon Monoxide; Ethanol; Food; Gasoline; Humans; Nitrogen Oxides; Refuse Disposal; Solid | 2022 |
Variations in risks from smoking between high-income, middle-income, and low-income countries: an analysis of data from 179 000 participants from 63 countries.
Topics: Adult; Aged; Carbon Monoxide; Cardiovascular Diseases; Developed Countries; Developing Countries; Fe | 2022 |
Short-term effect of fine particular matter on daily hospitalizations for ischemic stroke: A time-series study in Yancheng, China.
Topics: Adult; Air Pollutants; Air Pollution; Brain Ischemia; Carbon Monoxide; China; Environmental Exposure | 2021 |
SANGUINATE (PEGylated Carboxyhemoglobin Bovine): Mechanism of Action and Clinical Update.
Topics: Anemia; Anemia, Sickle Cell; Animals; Blood Substitutes; Brain Ischemia; Carbon Monoxide; Carboxyhem | 2017 |
Air pollution and cardiovascular events at labor and delivery: a case-crossover analysis.
Topics: Adult; Air Pollutants; Air Pollution; Carbon Monoxide; Cardiovascular Diseases; Cross-Over Studies; | 2017 |
Association between ambient air pollution and hospitalization for ischemic and hemorrhagic stroke in China: A multicity case-crossover study.
Topics: Air Pollutants; Air Pollution; Carbon Monoxide; China; Cities; Cross-Over Studies; Developing Countr | 2017 |
Characterization of Fine Particulate Matter and Associated Health Burden in Nanjing.
Topics: Adult; Aged; Air Pollutants; Carbon Monoxide; China; Environmental Monitoring; Female; Humans; Lung | 2018 |
Acute effects of air pollution on ischaemic stroke onset and deaths: a time-series study in Changzhou, China.
Topics: Adult; Age Distribution; Aged; Air Pollutants; Air Pollution; Brain Ischemia; Carbon Monoxide; China | 2018 |
Association between ambient air pollution and daily hospital admissions for ischemic stroke: A nationwide time-series analysis.
Topics: Adolescent; Adult; Aged; Air Pollutants; Air Pollution; Brain Ischemia; Carbon Monoxide; China; Citi | 2018 |
Time series analysis of ambient air pollution effects on dynamic stroke mortality.
Topics: Age Factors; Aged; Air Pollution; Carbon Monoxide; China; Female; Humans; Male; Middle Aged; Ozone; | 2020 |
Cerebrovascular ischaemia after carbon monoxide intoxication.
Topics: Brain; Brain Ischemia; Carbon Monoxide; Carbon Monoxide Poisoning; Carboxyhemoglobin; Creatine Kinas | 2015 |
Carbon monoxide and stroke: A time series study of ambient air pollution and emergency hospitalizations.
Topics: Aged; Aged, 80 and over; Air Pollution; Carbon Monoxide; Dose-Response Relationship, Drug; Emergency | 2015 |
Association of Exhaled Carbon Monoxide With Stroke Incidence and Subclinical Vascular Brain Injury: Framingham Heart Study.
Topics: Aged; Asymptomatic Diseases; Atherosclerosis; Brain; Breath Tests; Carbon Monoxide; Cerebral Infarct | 2016 |
Carbon monoxide poisoning and risk for ischemic stroke.
Topics: Carbon Monoxide; Carbon Monoxide Poisoning; Humans; Risk; Stroke | 2016 |
Patent foramen ovale in idiopathic pulmonary arterial hypertension: Long-term risk and morbidity.
Topics: Adult; Aged; Carbon Monoxide; Cardiac Catheterization; Echocardiography; Familial Primary Pulmonary | 2016 |
Association between short-term exposure to ultrafine particles and hospital admissions for stroke in Copenhagen, Denmark.
Topics: Aged; Air Pollutants; Atrial Fibrillation; Brain Ischemia; Carbon Monoxide; Cerebral Hemorrhage; Cro | 2010 |
Carbon monoxide-activated Nrf2 pathway leads to protection against permanent focal cerebral ischemia.
Topics: Active Transport, Cell Nucleus; Adaptor Proteins, Signal Transducing; Animals; Antimetabolites; Brai | 2011 |
Short-term effects of ambient particulates and gaseous pollutants on the incidence of transient ischaemic attack and minor stroke: a case-crossover study.
Topics: Adult; Aged; Aged, 80 and over; Air Pollutants; Carbon Monoxide; England; Female; Humans; Incidence; | 2012 |
Air pollution: a new risk factor in ischemic stroke mortality.
Topics: Air Pollution; Brain Ischemia; Carbon Monoxide; Cerebral Hemorrhage; Comorbidity; Environmental Moni | 2002 |
Relationship between ambient air pollution and hospital admissions for cardiovascular diseases in kaohsiung, taiwan.
Topics: Air Pollution; Carbon Monoxide; Cardiovascular Diseases; Cross-Over Studies; Environmental Monitorin | 2004 |
Outdoor air pollution and stroke in Sheffield, United Kingdom: a small-area level geographical study.
Topics: Age Factors; Aged; Air Pollutants; Air Pollution; Carbon Monoxide; Cerebrovascular Disorders; Ecolog | 2005 |
Heterogeneity of cardiovascular risk among smokers is related to degree of carbon monoxide exposure.
Topics: Aged; Aged, 80 and over; Arteriosclerosis; Carbon Monoxide; Humans; Incidence; Leg; Male; Myocardial | 2005 |
Modulation of thrombin-induced neuroinflammation in BV-2 microglia by carbon monoxide-releasing molecule 3.
Topics: Animals; Anti-Inflammatory Agents; Carbon Monoxide; Cell Hypoxia; Cells, Cultured; Heme Oxygenase (D | 2006 |
Associations between outdoor air pollution and emergency department visits for stroke in Edmonton, Canada.
Topics: Aged; Air Pollutants; Air Pollution; Canada; Carbon Monoxide; Cerebral Hemorrhage; Emergency Medical | 2006 |
Short-term effects of ozone air pollution on ischaemic stroke occurrence: a case-crossover analysis from a 10-year population-based study in Dijon, France.
Topics: Acute Disease; Adult; Age Factors; Aged; Air Pollutants; Arteries; Carbon Monoxide; Climate; Epidemi | 2007 |